The effect of omega-3 fatty acids on depressive symptoms and inflammatory markers in maintenance hemodialysis patients: a randomized, placebo-controlled clinical trial. (Q48331973)

From Wikidata

Jump to navigation Jump to search

scientific article published on 20 March 2014

Language	Label	Description	Also known as
English	The effect of omega-3 fatty acids on depressive symptoms and inflammatory markers in maintenance hemodialysis patients: a randomized, placebo-controlled clinical trial.	scientific article published on 20 March 2014

Statements

scholarly article

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/24643636

The effect of omega-3 fatty acids on depressive symptoms and inflammatory markers in maintenance hemodialysis patients: a randomized, placebo-controlled clinical trial. (English)

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/24643636

Afshin Gharekhani

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24643636%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Seyed Saeed Hashemi Nazari

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24643636%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Mohammad Ali Mansournia

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24643636%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Mohammad-Reza Khatami

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24643636%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Simin Dashti-Khavidaki

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24643636%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Effat Razeghi

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24643636%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Ahmad-Ali Noorbala

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24643636%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

20 March 2014

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/24643636

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24643636%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

70

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24643636%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

655-665

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24643636%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24643636%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

https://scigraph.springernature.com/pub.10.1007/s00228-014-1666-1

0 references

Dietary omega-3 fatty acid, ratio of omega-6 to omega-3 intake, inflammation, and survival in long-term hemodialysis patients

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

Sertraline treatment is associated with an improvement in depression and health-related quality of life in chronic peritoneal dialysis patients

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

Depression and renal disease

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

Depression in end-stage renal disease patients: a critical review

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

Effect of n-3 fatty acids on nutritional status and inflammatory markers in haemodialysis patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

The effect of low-dose omega 3 fatty acids on the treatment of mild to moderate depression in the elderly: a double-blind, randomized, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

Investigating the inflammatory phenotype of major depression: focus on cytokines and polyunsaturated fatty acids

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

Validation of 2 depression screening tools in dialysis patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

The Beck Depression Inventory as a screening device for major depression in renal dialysis patients

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

Psychometric properties of a Persian-language version of the Beck Depression Inventory--Second edition: BDI-II-PERSIAN.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

Associations of polyunsaturated fatty acids with residual depression or anxiety in older people with major depression.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

Fish oil supplementation in the treatment of major depression: a randomised double-blind placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

Omega-3 fatty acids and monoamine neurotransmission

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

Red blood cell fatty acids are associated with depression in a case-control study of adolescents.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

High omega-6 and low omega-3 fatty acids are associated with depressive symptoms and neuroticism.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

Effect of intradialytic intravenous administration of omega-3 fatty acids on nutritional status and inflammatory response in hemodialysis patients: a pilot study.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

Meta-Analysis of the Effects of Eicosapentaenoic Acid (EPA) in Clinical Trials in Depression

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

Eicosapentaenoic acid appears to be the key omega-3 fatty acid component associated with efficacy in major depressive disorder: a critique of Bloch and Hannestad and updated meta-analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

IL-6 levels decrease with SSRI treatment in patients with major depression.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

A psychoneuroimmunological review on cytokines involved in antidepressant treatment response

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

Fish oil as a management component for mood disorders - an evolving signal

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

Fish oil supplementation lowers C-reactive protein levels independent of triglyceride reduction in patients with end-stage renal disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

Review of the effects of omega-3 supplementation in dialysis patients

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

Marine n-3 polyunsaturated fatty acids in patients with end-stage renal failure and in subjects without kidney disease: a comparative study.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1666-1

21 January 2018

Depression in End-Stage Renal Disease: Current Advances and Research

1 reference

https://pubmed.ncbi.nlm.nih.gov/24643636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between a pro- and anti-inflammatory cytokine imbalance and depression in haemodialysis patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24643636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24643636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24643636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of omega-3 fatty acids in mood disorders - a systematic review and metaanalysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24643636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Could depression be a new branch of MIA syndrome?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24643636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24643636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Emotional symptoms, quality of life and cytokine profile in hemodialysis patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24643636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depressive symptoms and proinflammatory cytokine levels in chronic renal failure patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24643636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison between the AA/EPA ratio in depressed and non depressed elderly females: omega-3 fatty acid supplementation correlates with improved symptoms but does not change immunological parameters.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24643636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depression, nutritional status, and serum cytokines in peritoneal dialysis patients: is there a relationship?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24643636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of depression with markers of nutrition and inflammation in chronic kidney disease and end-stage renal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24643636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depression in chronic dialysis patients: assessment and treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/24643636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of depression symptoms and serum levels of interleukin-6 in hemodialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24643636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48331973&oldid=2122732308"